Nasdaq's $100 Million Kraken Bet Is a Wager That Tokens Become Real Shares

Nasdaq just paid $100 million for a stake in Payward, the parent of crypto exchange Kraken, at a valuation of $21 billion. To a company doing roughly $2.2 billion in annual revenue, a $100 million check is almost pocket change. So the interesting question is not the money. It is what Nasdaq is buying alongside it: a storefront in front of Kraken's customers for a product that does not exist yet.

That product is the Nasdaq Equity Token, and it is scheduled to launch on Kraken in the second quarter of next year. The small print is where the meaning lives. Most tokenized "stocks" sold today — including the ones on Kraken's own xStocks platform — are legally structured as debt instruments that track a share's price without giving the holder any claim to the underlying company or a vote. Nasdaq's design is different: the voting rights stay attached to the token. Buy the token, and you hold something closer to a real share, tradeable around the clock, than a price tracker.

That one choice is the whole bet, and it is worth unpacking before judging the valuation.

The part most headlines skip

For years, the tokenized-stock market has been built on a workaround. What retail users actually buy in these products is economic exposure — a certificate that rises and falls with Apple or Tesla — while the actual shares sit in custody somewhere and the holder has no shareholder rights. Kraken's xStocks, which launched in May 2025 on the Solana blockchain with roughly 60 tickers, works exactly this way: its documents state plainly that holders are not registered shareholders and hold no voting rights.

Nasdaq's Equity Tokens reject that shortcut. The exchange is attaching real shareholder voting rights to the token, and it has said it wants issuers, not intermediaries, to control what happens to their shares in tokenized form. This is the difference between a shadow market and the real one moving on chain. It is also why the deal carries legal weight: the SEC approved the rule change letting these trade only in March, under Chairman Paul Atkins, whose tenure has been broadly supportive of tokenization.

The ownership question is not settled everywhere, and disputes already show the fault line. AMC Entertainment recently accused Robinhood of creating an unauthorized market in its shares through a tokenized product overseas; Robinhood defended the product by arguing brokerages can create instruments tied to public stocks without a company's permission. That is precisely the ambiguity Nasdaq's voting-bearing token is trying to retire — and it is a reminder that "real share" is a legal claim that must hold up jurisdiction by jurisdiction, not just a technical label.

Who keeps the value

Set the legal fight aside and ask the game-theory question: what behaviour is each side really buying? Nasdaq, an incumbent exchange, is paying for distribution — access to Kraken's non-U.S. retail users who want 24/7 trading, a constituency the NYSE is chasing with its own around-the-clock blockchain venue built with BNY and Citi. Kraken already has a head start here; its xStocks franchise has passed $25 billion in cumulative trading volume and grown to about 100 equities. Nasdaq contributes the regulated rails, the settlement, and its market-surveillance tools to police the venue.

That split matters for anyone trying to figure out where durable value lands. Kraken is the shop window: it hosts the flow, charges trading fees, and reaches customers Nasdaq cannot reach directly. But the shares themselves, and the governance attached to them, sit on Nasdaq's regulated rails. So far, Kraken's claim on the economics is a venue fee on traffic, which is a thinner and more contestable position than owning the settlement and the rights. The partnership makes the platform busier; it does not yet prove Kraken captures an expanding share of the value it moves.

What $21 billion encodes

Now the scoreboard. Service estimates put Kraken's 2025 revenue at $2.2 billion, up a third from the year before, on about $2 trillion of trading volume, with roughly $530 million of adjusted EBITDA — a margin near 24%. On that base, the $21 billion round is close to 9.5 times trailing revenue, in line with the level the company has been pricing itself at all year: $15 billion last September, $20 billion in November, and now $21 billion. This is not a fresh leap; it is the same round of marks, slightly higher.

The deeper tension is the difference in scale between Kraken's core business and the thing the partnership is about. The entire market for tokenized stocks, by the most generous public counts, is around $2 billion — barely the size of Kraken's own revenue and a rounding error next to its $2 trillion of annual volume. Nasdaq's tokens do not launch until the second quarter of 2027. So the $21 billion is not pricing a product that exists; it is pricing the promise that tokenized equity becomes real, plus Nasdaq's decision to treat a crypto exchange as the distribution arm of the next securities market.

For an ordinary investor, two things follow. You cannot buy Kraken directly — it is private, with an IPO that has slipped to as early as the second quarter of 2027 — so the round is a signal about the market's direction and a mark worth remembering when Payward files, more than a trade. And the wager itself is unproven: a product that legally behaves like a share, cleared regulator by regulator, deployed at meaningful scale, is a year-and-a-half of execution and litigation away. Nasdaq's $100 million is a down payment on that possibility. The equity-token market will have to grow well beyond novelty — and Kraken will have to keep more than traffic fees — before the check looks cheap.